Starting in the 1990s, drugs targeting molecules on cancer cells like HER2 became available.

Phosphoinositides have a pivotal role as precursors to important second messengers and as bona fide signaling and scaffold targeting molecules.

Targeting molecules that promote T-cell survival may therefore provide an alternative strategy to classic adjuvants.

Targeting molecules that promote …